共 314 条
[31]
Pearce FA(2020)Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis Ann Rheum Dis 79 1243-649
[32]
McGrath C(2020)Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis N Engl J Med 382 622-659
[33]
Sandhu R(2010)Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 221-777
[34]
Packham J(2018)Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids Ann Rheum Dis 77 644-743
[35]
Watts RA(2021)Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis Ann Hematol 100 653-1378
[36]
Rhodes B(2009)Self-reported antibiotic allergy incidence and prevalence: age and sex effects Am J Med 122 778.e771-undefined
[37]
Al-Jayyousi R(2008)Emergency department visits for antibiotic-associated adverse events Clin Infect Dis 47 735-undefined
[38]
Harper L(2014)Sex-based disparities in cardioprotective medication use in adults with diabetes Diabetol Metab Syndr 6 117-undefined
[39]
Obrenovic K(2022)Analysis of the relationship between sex and prescriptions for guideline-recommended therapy in peripheral arterial disease, in relation to 1-year all-cause mortality: a primary care cohort study BMJ Open 12 e055952-undefined
[40]
Lanyon P(2021)Long-term safety of rituximab in granulomatosis with polyangiitis and in microscopic polyangiitis Arthritis Care Res (Hoboken) 73 1372-undefined